Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases
Globenewswire· 2025-09-15 20:00
SPY072 is a potential first- and best-in-class anti-TL1A antibody for rheumatic diseases targeting quarterly or twice-yearly subcutaneous dosing SKYWAY study is evaluating SPY072 in patients with moderate-to-severely active rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) Proof-of-concept data for all three indications are expected in 2026 SKYLINE and SKYWAY trials are expected to provide 9 proof-of-concept readouts in 2026-27 WALTHAM, Mass., Sept. 15, 2025 (GLOBE NE ...
Schouw & Co. share buy-back programme, week 37 2025
Globenewswire· 2025-09-15 20:00
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Tr ...
Skanska Advanced Technology Expands to Address Data Center and Semiconductor Markets
Globenewswire· 2025-09-15 20:00
Redefines Delivery of Advanced Technology Construction Projects with New Centralized and Simplified ModelNEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Skanska, a leading global development and construction firm, today announced a strategic realignment of its Skanska Advanced Technology (SAT) division, uniting its proven mission-critical infrastructure capabilities with its rapidly growing semiconductor delivery group. This integrated approach positions SAT to better meet rising demand across both sectors, of ...
Vortex Energy Completes Ambient Noise Tomography (ANT) Field Program at Robinsons River Salt Project
Globenewswire· 2025-09-15 20:00
VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the successful completion of the field component of its Ambient Noise Tomography (“ANT”) survey at the Robinsons River Salt Project, located in Newfoundland. Between July 31 and August 26, 2025, a total of 188 GTI NuSeis NRU D3 tri-axial digital nodal instruments, each equipped with 5 Hz geophones, were deployed across the property. The su ...
Pan American Energy to Begin Fieldwork at the Tharsis Project
Globenewswire· 2025-09-15 20:00
Phase 1 Fieldwork Kicks Off to Build Geological Understanding and Guide Future DrillingCALGARY, Alberta, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTC: PAANF | FRA: SS6) (“Pan American” or the “Company”) is pleased to announce the first phase of development at the newly acquired Tharsis Project (see details about the project agreement in the June 16, 2025 news release). Phase 1 will mark the beginning of a structured, multi-step exploration plan designed to advance the projec ...
Collective Metals Announces the Appointment of Nick Standish as Director
Globenewswire· 2025-09-15 20:00
VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the “Company” or “Collective”) is pleased to announce the appointment of Mr. Nick Standish as a director of the Company (the “Appointment”). Mr. Standish is a seasoned entrepreneur and dealmaker with 17 years of experience in venture capital, corporate finance and global business. Nick Standish, commented, “I am very excited to be joining Collective Metals as a director. I’m confident ...
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
Globenewswire· 2025-09-15 20:00
Revised label allows treatment of DEB patients from birth VYJUVEK can now be applied by patients and caregivers PITTSBURGH, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) approved a label update for VYJUVEK® (beremagene geperpavec-svdt) that expands the VYJUVEK eligible patient population to include dystrophic epidermolysis bullosa (DEB) patients from birth and provides patients full flexibili ...
CN Partners with the New Orleans Saints to Promote Rail Safety
Globenewswire· 2025-09-15 20:00
HOMEWOOD, Ill., Sept. 15, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today announced a partnership with the New Orleans Saints during See Tracks? Think Train® Week, taking place September 15 to 19. As part of the campaign, CN Police officers will join members of the New Orleans Saints in visiting schools across New Orleans to raise awareness about the importance of staying safe around railway tracks. Students will take part in activities designed to empower them to be safety leaders in their communi ...
Advanced Flower Capital Announces Dividend for the Third Quarter 2025
Globenewswire· 2025-09-15 20:00
股息分配 - 公司宣布2025年第三季度普通股每股季度股息为0.15美元 与第二季度持平 股息将于2025年10月15日支付给2025年9月30日登记在册的股东 [1][2] 股息决策依据 - 董事会每季度评估公司可分配收益以确定股息水平 主要考虑当前处于非应计状态贷款的还款时间及规模不确定性 [2] - 可分配收益是衡量股息支付能力的关键指标 其计算排除股票补偿、折旧摊销、未实现损益等非现金项目 但包含递延利息投资的应计收入 [4][6][8] 公司业务概览 - 公司是一家商业抵押房地产投资信托基金 专注于发起、构建、承销及管理高级担保抵押贷款和其他债务证券 特别针对已合法化医疗或成人用大麻州的行业运营商 [3] - 通过管理团队深厚的行业网络和信贷专长 公司通常发起1000万至超过1亿美元规模的贷款 以优质房地产资产、许可证价值及现金流作为担保 [3] 财务指标定义 - 可分配收益为非GAAP指标 用于评估剔除特定交易及GAAP调整后的业绩 管理层认为该指标有助于投资者评估业务整体表现 [4][6][9] - 该指标计算方式与核心收益类似 但核心收益计算不考虑激励性薪酬支出 而可分配收益包含该期间应计激励薪酬 [5] REIT税务要求 - 作为REIT 公司需将年度REIT应税收入的至少90%进行分配 若分配比例低于100% 则需按常规公司税率纳税 [7] - 董事会授权股息时综合考虑多因素 可分配收益虽非直接衡量净应税收入 但是股息支付能力的有效指示指标 [7][8]
Terra Innovatum and GSR III Acquisition Corp. Announce Effectiveness of S-4 and Set Extraordinary General Meeting Date to Approve Business Combination
Globenewswire· 2025-09-15 20:00
Extraordinary General Meeting of Shareholders to be Held on October 7, 2025NEW YORK and AUSTIN, Texas, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. ("GSRT") (Nasdaq: GSRT), a publicly traded special purpose acquisition company, today announced that on September 12, 2025, the U.S. Securities and Exchange Commission (“SEC”) declared effective the registration statement on Form S-4, as ...